Quantcast
Home » Topics » vemurafenib

New melanoma treatment breakthrough boost survival: studies

CHICAGO — Two new treatments, including therapy blocking a gene mutation occurring in half of melanoma patients, are prolonging lives of people suffering from the deadliest form of skin cancer, clinical trials unveiled Sunday show. Vemurafenib neutralizes mutation of the key BRAF gene by inhibiting production of a protein which…

Google+